Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 197

Can socially responsible investing and good returns coexist?

“Do the right thing. It will gratify some people and astonish the rest.” Mark Twain

In the past few years, there has been a significant increase in the interest in environmental, social and governance (ESG) investing. According to a paper released recently, more than $8 trillion of the $40 trillion of money managed in the USA is now under some form of Sustainable and Responsible Investing (SRI) or ESG, up 33% since 2014 and up fivefold from $1.4 trillion in 2012 for money run by fund managers.

Australian fund managers caught unready for this change

If we look at the Mercer survey data for January 2017, the Global Equities strategy section contains 127 global funds sold in Australia. Of this, only five are classed as SRI funds. It is somewhat better for Australian equities with 157 funds in the survey, of which 13 are SRI. If we were to use the ratio of assets in the USA, the number of SRI funds should be 27 and 34 respectively.

One reason could be the view among many people, particularly fund managers, that ‘you can’t have your cake and eat it, too’, that SRI means lower returns for investors.

This misconception of accepting lower returns for being ethical goes against another tenet of conventional investing wisdom: buy good businesses. In his letters to Berkshire Hathaway shareholders, Warren Buffett often discusses the importance of ethics and the quality of the character of the people running the businesses he owns.

Implicitly he is saying that businesses which have an ethos and focus on ‘doing the right thing’ by staff and customers should generate higher returns. Admittedly, he is discussing the character of the people rather than the nature of the business, and some people would find owning Coca-Cola shares unethical. It’s this differentiation between good people and bad unethical businesses that opens an interesting next line of inquiry.

What do the statistics say?

UBS recently published an excellent summary of academic literature which concluded that SRI did not negatively affect investor returns.

Verheyden, Eccles & Feiner (2016) wanted to look at whether a portfolio manager would be at a disadvantage in terms of performance, risk, and diversification if he/she were to start from a screen based on ESG criteria. The empirical evidence shows that all ESG-screened portfolios have performed similarly to their respective underlying benchmarks, if not slightly outperforming them. Put differently, the findings of the paper show that, at the very least, there is no performance penalty from screening out low ESG-scoring firms in each industry.

This is consistent with our own experience as portfolio managers at Hunter Hall, where we outperformed against an all-inclusive benchmark, despite having a restricted ownership list.

Nagy, Kassam & Lee (2016) wanted to see not only if highly-rated ESG companies outperform, but if businesses are rewarded for improving, going from okay to good? The answer was unequivocally yes. Both outperformed, but the improvers outperformed at double the rate.

The most interesting article by Statman and Glushkov (2016) created what they called 'Top Minus Bottom' (TMB) where stocks were ranked on their ESG criteria and then modelled how being long the ‘better-ranked’ versus the ‘worse-ranked’ performed. This concept is similar to the studies above and could be called the ‘good screen’.

The innovation was to look at ‘Accepted Minus Shunned’ (AMS) separately. Here the authors looked at the returns from stocks commonly accepted in SRI funds versus those that are typically avoided. Shunned companies are those with operations in the tobacco, alcohol, gambling, military, firearms and nuclear industries. Call this the “negative screen”.

Like the earlier studies, it was found TMB outperformed the broader market but interestingly the AMS (the bad screen) stocks didn’t outperform, that is, the excluded stocks did better than the broader market. But AMS under-performed by less than the TMB screen outperformed. That is, it was a net positive for investors. I think it is this AMS effect that fund managers have focused on in their view that SRI/ESG does not work.

What does this mean for fund managers?

Investors globally are demanding more focus from their fund managers on ESG issues. The implications of these studies are that ESG does not detract from returns and investors are therefore not irrational to ask for more focus on ESG and SRI issues by their money managers.

But it also says running a positive screen in combination with running a negative screen is a better way to generate returns for investors while also satisfying investor’s ethical investment needs.

 

Chad Slater, CFA, is Joint CIO of Morphic Asset Management. This article is general information that does not consider the circumstances of any individual.

  •   5 April 2017
  • 1
  •      
  •   

RELATED ARTICLES

Top 10 ESG issues for 2019

Is the fossil fuel narrative simply too convenient?

Elevating responsible investing to solve real world challenges

banner

Most viewed in recent weeks

The growing debt burden of retiring Australians

More Australians are retiring with larger mortgages and less super. This paper explores how unlocking housing wealth can help ease the nation’s growing retirement cashflow crunch.

LICs vs ETFs – which perform best?

With investor sentiment shifting and ETFs surging ahead, we pit Australia’s biggest LICs against their ETF rivals to see which delivers better returns over the short and long term. The results are revealing.

Warren Buffett's final lesson

I’ve long seen Buffett as a flawed genius: a great investor though a man with shortcomings. With his final letter to Berkshire shareholders, I reflect on how my views of Buffett have changed and the legacy he leaves.

Family trusts: Are they still worth it?

Family trusts remain a core structure for wealth management, but rising ATO scrutiny and complex compliance raise questions about their ongoing value. Are the benefits still worth the administrative burden?

13 ways to save money on your tax - legally

Thoughtful tax planning is a cornerstone of successful investing. This highlights 13 legal ways that you can reduce tax, preserve capital, and enhance long-term wealth across super, property, and shares.

Why it’s time to ditch the retirement journey

Retirement isn’t a clean financial arc. Income shocks, health costs and family pressures hit at random, exposing the limits of age-based planning and the myth of a predictable “retirement journey".

Latest Updates

Weekly Editorial

Welcome to Firstlinks Edition 639

Thank you for the hundreds of responses to our Reader Survey and to maximise the sample size, we’re leaving it open until this Sunday. Here is an overview of the results so far.

  • 27 November 2025
  • 1
Investment strategies

Where to hide in the ‘everything bubble’

It might not be quite an ‘everything bubble’ but there’s froth in many assets, not just US stocks, right now. It might be time to stress test your portfolio and consider assets that could offer you shelter if trouble is coming.

Investment strategies

The ultimate investing hack: dividend growth stocks

Investors often fall prey to ‘amygdala hijacks,’ letting emotion trump reason. By focusing on dividend-growth with stocks instead of volatile prices, you can steady your mindset and let compounding do the work. 

Investment strategies

CBA or global banks?

CBA’s recent pullback highlights single-stock risk. Global banks trade at lower P/Es with rising earnings and dividends, offering investors both income potential and long-term value beyond the local market.

Investment strategies

Global dividends rising, but Australia lags

Global dividend growth surged in the third quarter, with median growth of almost 6%. Australia was a notable exception as dividends fell, thanks to flagging mining company payouts.

Economy

I called inflation's rise and fall and here's what's next

In 2020, I warned that surging US money supply growth would spark inflation. By early 2023, I said US money supply was dropping dramatically and that meant inflation would decline. Here's what happens next.

Superannuation

Are excessive super funds giving Australia “Dutch Disease”?

The irony is profound: a system designed to secure Australians’ futures may be systematically dismantling the economic diversity necessary for long-term prosperity.

Investment strategies

Could your children pass the inheritance ‘stress test’?

You devote years of your life working, saving and investing, striving to build a legacy that will outlive you. Before any wealth moves to the next generation, here are six questions every parent should ask themselves.

Sponsors

Alliances

© 2025 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.